{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:04:41Z","timestamp":1790827481465,"version":"4.1.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004625","name":"Universiti Teknologi MARA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004625","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03345-2","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:37:18Z","timestamp":1773700638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nanoformulations in Acne Therapy: Translational Opportunities and Barriers for Next-Generation Topical Treatments"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-4774","authenticated-orcid":false,"given":"Mohd Faiz","family":"Mustaffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0766-3239","authenticated-orcid":false,"given":"Nur Shareena Maisarah","family":"Mohd Ghazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-7752","authenticated-orcid":false,"given":"Syed Haroon","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0116-7040","authenticated-orcid":false,"given":"Khuriah","family":"Abdul Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"3345_CR1","doi-asserted-by":"publisher","unstructured":"Zhu Z, Zhong X, Luo Z, Liu M, Zhang H, Zheng H, et al. Global, regional and national burdens of acne vulgaris in\u00a0adolescents and young adults aged 10\u201324\u2005years from 1990 to 2021: a trend analysis. British Journal of Dermatology. Oxford University Press; 2025;192:228\u201337. https:\/\/doi.org\/10.1093\/bjd\/ljae352","DOI":"10.1093\/bjd\/ljae352"},{"issue":"4","key":"3345_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bjd.20882","volume":"186","author":"H Chen","year":"2022","unstructured":"Chen H, Zhang TC, Yin XL, Man JY, Yang XR, Lu M. Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019. Br J Dermatol. 2022;186(4):673\u201383. https:\/\/doi.org\/10.1111\/bjd.20882.","journal-title":"Br J Dermatol"},{"key":"3345_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101578","volume":"36","author":"M Vasam","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023;36:101578. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101578.","journal-title":"Biochem Biophys Rep"},{"key":"3345_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121217","author":"AT Ogunjimi","year":"2021","unstructured":"Ogunjimi AT, Chahud F, Lopez RFV, Elsevier B.V. Isotretinoin-Delonix polymeric nanoparticles: potentials for skin follicular targeting in acne treatment. Int J Pharm. 2021. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121217.","journal-title":"Int J Pharm"},{"key":"3345_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18794","author":"C Mias","year":"2023","unstructured":"Mias C, Mengeaud V, Bessou-Touya S, Duplan H, John Wiley and Sons Inc. Recent advances in understanding inflammatory acne: deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway. J Eur Acad Dermatol Venereol. 2023. https:\/\/doi.org\/10.1111\/jdv.18794.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3345_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.09.001","author":"S Knutsen-Larson","year":"2012","unstructured":"Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP. Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin. 2012. https:\/\/doi.org\/10.1016\/j.det.2011.09.001.","journal-title":"Dermatol Clin"},{"key":"3345_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/276260","author":"A Vyas","year":"2014","unstructured":"Vyas A, Kumar Sonker A, Gidwani B, ScientificWorld Ltd. Carrier-based drug delivery system for treatment of acne. Sci World J. 2014. https:\/\/doi.org\/10.1155\/2014\/276260.","journal-title":"Sci World J"},{"key":"3345_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/0124681873307635240520074626","volume":"15","author":"A Kumar","year":"2025","unstructured":"Kumar A, Kumar A, Islam MM, Gupta GD, Kumar M. Transferosomes: advancing vesicular drug delivery systems for dermatological disorders - a comprehensive review. Curr Nanomed. 2025;15:226\u201340. https:\/\/doi.org\/10.2174\/0124681873307635240520074626.","journal-title":"Curr Nanomed"},{"key":"3345_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1124\/pharmrev.123.000549","volume":"76","author":"M Brown","year":"2024","unstructured":"Brown M, Williams A, Chilcott RP, Brady B, Lenn J, Evans C, et al. Topically applied therapies for the treatment of skin disease: past, present, and future. Pharmacol Rev. 2024;76:689\u2013790. https:\/\/doi.org\/10.1124\/pharmrev.123.000549.","journal-title":"Pharmacol Rev"},{"key":"3345_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2021.100063","volume":"4","author":"T Coenye","year":"2022","unstructured":"Coenye T, Spittaels K-J, Achermann Y. The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes. Biofilm. 2022;4:100063. https:\/\/doi.org\/10.1016\/j.bioflm.2021.100063.","journal-title":"Biofilm"},{"key":"3345_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945-973.e33. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.037.","journal-title":"J Am Acad Dermatol"},{"key":"3345_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2021.1951218","author":"AC Paiva-Santos","year":"2021","unstructured":"Paiva-Santos AC, Mascarenhas-Melo F, Coimbra SC, Pawar KD, Peixoto D, Ch\u00e1-Ch\u00e1 R, et al. Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients. Expert Opin Drug Deliv. 2021. https:\/\/doi.org\/10.1080\/17425247.2021.1951218.","journal-title":"Expert Opin Drug Deliv"},{"key":"3345_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8070987","author":"YB Lee","year":"2019","unstructured":"Lee YB, Byun EJ, Kim HS, MDPI. Potential role of the microbiome in acne: A comprehensive review. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8070987.","journal-title":"J Clin Med"},{"key":"3345_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1565111","author":"C Zhu","year":"2025","unstructured":"Zhu C, Wei B, Li Y, Wang C, Frontiers Media SA. Antibiotic resistance rates in Cutibacterium acnes isolated from patients with acne vulgaris: a systematic review and meta-analysis. Front Microbiol. 2025. https:\/\/doi.org\/10.3389\/fmicb.2025.1565111.","journal-title":"Front Microbiol"},{"key":"3345_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125385","volume":"673","author":"M Tarek","year":"2025","unstructured":"Tarek M, El-Gogary RI, Kamel AO. A new era of psoriasis treatment: drug repurposing through the lens of nanotechnology and machine learning. Int J Pharm. 2025;673:125385. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125385.","journal-title":"Int J Pharm"},{"key":"3345_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.abd.2024.06.001","volume":"99","author":"PR Criado","year":"2024","unstructured":"Criado PR, Miot HA, Bueno-Filho R, Ianhez M, Criado RFJ, de Castro CCS. Update on the pathogenesis of atopic dermatitis. An Bras Dermatol. 2024;99:895\u2013915. https:\/\/doi.org\/10.1016\/j.abd.2024.06.001.","journal-title":"An Bras Dermatol"},{"key":"3345_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1080\/17425247.2021.1919618","volume":"18","author":"G Sharma","year":"2021","unstructured":"Sharma G, Yachha Y, Thakur K, Mahajan A, Kaur G, Singh B, et al. Co-delivery of isotretinoin and clindamycin by phospholipid-based mixed micellar system confers synergistic effect for treatment of acne vulgaris. Expert Opin Drug Deliv. 2021;18:1291\u2013308. https:\/\/doi.org\/10.1080\/17425247.2021.1919618.","journal-title":"Expert Opin Drug Deliv"},{"key":"3345_CR18","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2014.916715","author":"T Garg","year":"2016","unstructured":"Garg T, Taylor and Francis Ltd. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 2016. https:\/\/doi.org\/10.3109\/21691401.2014.916715.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3345_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119140","author":"R Patel","year":"2020","unstructured":"Patel R, Prabhu P. Nanocarriers as versatile delivery systems for effective management of acne. Int J Pharm. 2020. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119140.","journal-title":"Int J Pharm"},{"key":"3345_CR20","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S237508","author":"A Mancuso","year":"2020","unstructured":"Mancuso A, Cristiano MC, Fresta M, Paolino D. The challenge of nanovesicles for selective topical delivery for acne treatment: enhancing absorption whilst avoiding toxicity. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S237508.","journal-title":"Int J Nanomedicine"},{"key":"3345_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4103\/0378-6323.98077","volume":"78","author":"S Prasad","year":"2012","unstructured":"Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, et al. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Indian J Dermatol Venereol Leprol. 2012;78:459\u201367. https:\/\/doi.org\/10.4103\/0378-6323.98077.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3345_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.nano.2014.02.012","volume":"10","author":"R Pati","year":"2014","unstructured":"Pati R, Mehta RK, Mohanty S, Padhi A, Sengupta M, Vaseeharan B, et al. Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomedicine. 2014;10:1195\u2013208. https:\/\/doi.org\/10.1016\/j.nano.2014.02.012.","journal-title":"Nanomedicine"},{"key":"3345_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics12030106","volume":"12","author":"DL Gugulu\u0219","year":"2025","unstructured":"Gugulu\u0219 DL, V\u00e2\u021b\u0103 D, Popescu IA, P\u0103tra\u0219cu AI, Halip IA, Mocanu M, et al. The epidemiology of acne in the current era: trends and clinical implications. Cosmetics. 2025;12:106. https:\/\/doi.org\/10.3390\/cosmetics12030106.","journal-title":"Cosmetics"},{"key":"3345_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247535","author":"A Tobiasz","year":"2022","unstructured":"Tobiasz A, Nowicka D, Szepietowski JC. Acne vulgaris\u2014novel treatment options and factors affecting therapy adherence: a narrative review. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11247535.","journal-title":"J Clin Med"},{"key":"3345_CR25","doi-asserted-by":"publisher","unstructured":"Dreno B, Amici JM, Demessantflavigny AL, Wright C, Taieb C, Desai SR, et al. The impact of acne, atopic dermatitis, skin toxicities and scars on quality of life and the importance of a holistic treatment approach. Clin Cosmet Investig Dermatol. Dove Medical Press Ltd; 2021. p. 623\u201332. https:\/\/doi.org\/10.2147\/CCID.S315846","DOI":"10.2147\/CCID.S315846"},{"key":"3345_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101578","author":"M Vasam","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101578.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"3345_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.29","volume":"1","author":"S Moradi Tuchayi","year":"2015","unstructured":"Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;15029. https:\/\/doi.org\/10.1038\/nrdp.2015.29.","journal-title":"Nat Rev Dis Primers"},{"key":"3345_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0846.2011.00542.x","author":"R Ramli","year":"2012","unstructured":"Ramli R, Malik AS, Hani AFM, Jamil A. Acne analysis, grading and computational assessment methods: an overview. Skin Res Technol. 2012. https:\/\/doi.org\/10.1111\/j.1600-0846.2011.00542.x.","journal-title":"Skin Res Technol"},{"key":"3345_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105238","author":"HL Kelh\u00e4l\u00e4","year":"2014","unstructured":"Kelh\u00e4l\u00e4 HL, Palatsi R, Fyhrquist N, Lehtim\u00e4ki S, V\u00e4yrynen JP, Kallioinen M, et al. IL-17\/Th17 pathway is activated in acne lesions. PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0105238.","journal-title":"PLoS One"},{"key":"3345_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21739","author":"I Mavranezouli","year":"2022","unstructured":"Mavranezouli I, Daly CH, Welton NJ, Deshpande S, Berg L, Bromham N, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris*. Br J Dermatol. 2022. https:\/\/doi.org\/10.1111\/bjd.21739.","journal-title":"Br J Dermatol"},{"key":"3345_CR31","unstructured":"National Institute of Health and Care Excellence. Acne vulgaris: management, NICE Guideline [Internet]. 2nd ed. British Association of Dermatologists; 2024. https:\/\/www.nice.org.uk\/guidance\/ng198.\u00a0Accessed\u00a0 15 Mar 2025."},{"key":"3345_CR32","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1582-x","author":"SN Murthy","year":"2020","unstructured":"Murthy SN. Approaches for delivery of drugs topically. AAPS PharmSciTech. 2020. https:\/\/doi.org\/10.1208\/s12249-019-1582-x.","journal-title":"AAPS PharmSciTech"},{"key":"3345_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111403","author":"S Brito","year":"2024","unstructured":"Brito S, Baek M, Bin BH. Skin structure, physiology, and pathology in topical and transdermal drug delivery. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16111403.","journal-title":"Pharmaceutics"},{"key":"3345_CR34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","volume":"12","author":"D Ramadon","year":"2022","unstructured":"Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12:758\u201391. https:\/\/doi.org\/10.1007\/s13346-021-00909-6.","journal-title":"Drug Deliv Transl Res"},{"key":"3345_CR35","doi-asserted-by":"publisher","unstructured":"Patel K, Nole K, Fleischer A. Acne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance. J Drugs Dermatol. 2021;20:648\u201351. https:\/\/doi.org\/10.36849\/JDD.2021.5727","DOI":"10.36849\/JDD.2021.5727"},{"key":"3345_CR36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90820","author":"I Bouchelkia","year":"2025","unstructured":"Bouchelkia I, Tyring S. Topical Isotretinoin: Current Applications, Challenges, and Future Directions. Cureus. 2025;17:e90820. https:\/\/doi.org\/10.7759\/cureus.90820","journal-title":"Cureus"},{"key":"3345_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jamadermatol.2014.5254","volume":"151","author":"KL Anderson","year":"2015","unstructured":"Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015;151:623\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2014.5254.","journal-title":"JAMA Dermatol"},{"key":"3345_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.11074","author":"D Branisteanu","year":"2021","unstructured":"Branisteanu D, Toader M, Porumb E, Serban I, Pinzariu A, Branisteanu C, et al. Adult female acne: clinical and therapeutic particularities (Review). Exp Ther Med. 2021. https:\/\/doi.org\/10.3892\/etm.2021.11074.","journal-title":"Exp Ther Med"},{"key":"3345_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2017.10.006","author":"AU Tan","year":"2018","unstructured":"Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol. 2018. https:\/\/doi.org\/10.1016\/j.ijwd.2017.10.006.","journal-title":"Int J Womens Dermatol"},{"key":"3345_CR40","doi-asserted-by":"publisher","DOI":"10.4161\/derm.3.1.13900","author":"E Makrantonaki","year":"2011","unstructured":"Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011. https:\/\/doi.org\/10.4161\/derm.3.1.13900.","journal-title":"Dermatoendocrinol"},{"key":"3345_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","volume":"3","author":"A Naik","year":"2000","unstructured":"Naik A, Kalia Y, Guy R. Transdermal drug delivery: overcoming The skin\u2019s barrier function. Pharmaceutical Science & Technology Today. 2000;3:318\u201326. https:\/\/doi.org\/10.1016\/S1461-5347(00)00295-9.","journal-title":"Pharmaceutical Science & Technology Today"},{"key":"3345_CR42","doi-asserted-by":"publisher","unstructured":"Khanna C, Sharma P, Kaur S, Singh S, Rahar S, Kumar L, et al. TAZAROTENE: A Concise Review of Mechanism of Action and Therapeutic Benefits. Int J Life Sci Pharma Res. 2022; https:\/\/doi.org\/10.22376\/ijpbs\/lpr.2022.12.6.p207-219","DOI":"10.22376\/ijpbs\/lpr.2022.12.6.p207-219"},{"key":"3345_CR43","doi-asserted-by":"publisher","unstructured":"Mustaffa MF, Ramasamy K, Jaafar N, Hasan MH, Ramli NA, Suratman S, et al. In-situ film-forming solution for topical application of terbinafine hcl: Biopharmaceutical evaluation and in vivo antifungal performance using animal model. International Journal of Applied Pharmaceutics. Innovare Academics Sciences Pvt. Ltd; 2021;13:98\u2013105. https:\/\/doi.org\/10.22159\/ijap.2021v13i6.42589","DOI":"10.22159\/ijap.2021v13i6.42589"},{"key":"3345_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.01.006","author":"\u00d6 Kutlu","year":"2023","unstructured":"Kutlu \u00d6, Karada\u011f AS, Wollina U. Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment. An Bras Dermatol. 2023. https:\/\/doi.org\/10.1016\/j.abd.2022.01.006.","journal-title":"An Bras Dermatol"},{"key":"3345_CR45","unstructured":"Del Rosso JQ. Benzoyl Peroxide Cleansers for the Treatment of Acne Vulgaris: Status Report on Available Data. Cutis 2008;82:336\u201342."},{"key":"3345_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004356","author":"C Briot","year":"2025","unstructured":"Briot C, Cassier P, Fredenucci I, Ehmke A, Durupt F, Merienne C, et al. Development of a 50% (w\/v) aluminium chloride hexahydrate solution as haemostatic agent. Eur J Hosp Pharm. 2025. https:\/\/doi.org\/10.1136\/ejhpharm-2024-004356.","journal-title":"Eur J Hosp Pharm"},{"key":"3345_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2022.102580","author":"C Abbott","year":"2022","unstructured":"Abbott C, Grout E, Morris T, Brown HL. Cutibacterium acnes biofilm forming clinical isolates modify the formation and structure of Staphylococcus aureus biofilms, increasing their susceptibility to antibiotics. Anaerobe. 2022. https:\/\/doi.org\/10.1016\/j.anaerobe.2022.102580.","journal-title":"Anaerobe"},{"key":"3345_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106834","author":"N Ram\u00edrez","year":"2024","unstructured":"Ram\u00edrez N, Cassola F, Gambero A, Sartoratto A, G\u00f3mez Castellanos LM, Ribeiro G, et al. Control of pathogenic bacterial biofilm associated with acne and the anti-inflammatory potential of an essential oil blend. Microb Pathog. 2024. https:\/\/doi.org\/10.1016\/j.micpath.2024.106834.","journal-title":"Microb Pathog"},{"key":"3345_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ejdv.ejdv_31_22","volume":"44","author":"R Kandhari","year":"2024","unstructured":"Kandhari R. Side effects of anti-acne medications: a narrative review. Egypt J Dermatol Venereol. 2024;44:1\u20136. https:\/\/doi.org\/10.4103\/ejdv.ejdv_31_22.","journal-title":"Egypt J Dermatol Venereol"},{"key":"3345_CR50","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1177\/0300060519847367","volume":"47","author":"B Sevimli Dikicier","year":"2019","unstructured":"Sevimli Dikicier B. Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate. J Int Med Res. 2019;47:2987\u201392. https:\/\/doi.org\/10.1177\/0300060519847367.","journal-title":"J Int Med Res"},{"key":"3345_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000066249","volume":"12","author":"J Lademann","year":"1999","unstructured":"Lademann J, Weigmann H-J, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol. 1999;12:247\u201356. https:\/\/doi.org\/10.1159\/000066249.","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"3345_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","volume":"66","author":"J Lademann","year":"2007","unstructured":"Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles \u2013 an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66:159\u201364. https:\/\/doi.org\/10.1016\/j.ejpb.2006.10.019.","journal-title":"Eur J Pharm Biopharm"},{"key":"3345_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.0022-202X.2004.22717.x","volume":"123","author":"R Toll","year":"2004","unstructured":"Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123:168\u201376. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.22717.x.","journal-title":"J Invest Dermatol"},{"key":"3345_CR54","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/sj.jid.5700226","volume":"126","author":"A Vogt","year":"2006","unstructured":"Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40nm, but not 750 or 1,500nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126:1316\u201322. https:\/\/doi.org\/10.1038\/sj.jid.5700226.","journal-title":"J Invest Dermatol"},{"key":"3345_CR55","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","volume":"3","author":"A Naik","year":"2000","unstructured":"Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin\u2019s barrier function. Pharm Sci Technol Today. 2000;3:318\u201326. https:\/\/doi.org\/10.1016\/S1461-5347(00)00295-9.","journal-title":"Pharm Sci Technol Today"},{"key":"3345_CR56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10787-999-0028-6","volume":"7","author":"MS Roberts","year":"1999","unstructured":"Roberts MS, Cross SE. Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems. Inflammopharmacology. 1999;7:339\u201350. https:\/\/doi.org\/10.1007\/s10787-999-0028-6.","journal-title":"Inflammopharmacology"},{"key":"3345_CR57","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.2147\/IJN.S335804","volume":"16","author":"JY Fang","year":"2021","unstructured":"Fang JY, Chou WL, Lin CF, Sung CT, Alalaiwe A, Yang SC. Facile biofilm penetration of cationic liposomes loaded with DNase I\/proteinase K to eradicate Cutibacterium acnes for treating cutaneous and catheter infections. Int J Nanomedicine. 2021;16:8121\u201338. https:\/\/doi.org\/10.2147\/IJN.S335804.","journal-title":"Int J Nanomedicine"},{"key":"3345_CR58","doi-asserted-by":"publisher","unstructured":"De Canha MN, Thipe VC, Katti K V., Mandiwana V, Kalombo ML, Ray SS, et al. The Activity of Gold Nanoparticles Synthesized Using Helichrysum odoratissimum Against Cutibacterium acnes Biofilms. Front Cell Dev Biol. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.675064","DOI":"10.3389\/fcell.2021.675064"},{"key":"3345_CR59","doi-asserted-by":"publisher","unstructured":"Abid F, Kim S, Savaliya B, Cesari L, Amirmostofian M, Abdella S, et al. Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers. Int J Nanomedicine. 2025;20:2181\u2013204. https:\/\/doi.org\/10.2147\/IJN.S497108","DOI":"10.2147\/IJN.S497108"},{"key":"3345_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020432","author":"K Ivanova","year":"2023","unstructured":"Ivanova K, Ramon E, Ivanova A, Sanchez-Gomez S, Tzanov T. Bio-based nano-enabled cosmetic formulations for the treatment of Cutibacterium acnes-associated skin infections. Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12020432.","journal-title":"Antioxidants"},{"key":"3345_CR61","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1021\/jf3010405","volume":"60","author":"LM Sun","year":"2012","unstructured":"Sun LM, Zhang CL, Li P. Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol. J Agric Food Chem. 2012;60:6150\u20136. https:\/\/doi.org\/10.1021\/jf3010405.","journal-title":"J Agric Food Chem"},{"key":"3345_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020310","author":"G Ferreres","year":"2023","unstructured":"Ferreres G, Ivanova K, Ivanov I, Tzanov T. Nanomaterials and coatings for managing antibiotic-resistant biofilms. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12020310.","journal-title":"Antibiotics"},{"key":"3345_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030396","author":"A Ahsan","year":"2024","unstructured":"Ahsan A, Thomas N, Barnes TJ, Subramaniam S, Loh TC, Joyce P, et al. Lipid nanocarriers-enabled delivery of antibiotics and antimicrobial adjuvants to overcome bacterial biofilms. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16030396.","journal-title":"Pharmaceutics"},{"key":"3345_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092156","author":"D Crainic","year":"2025","unstructured":"Crainic D, Popescu R, Vlad CD, Serban DV, Popa D, Popa CA, et al. Topical zinc oxide nanoparticle formulations for acne vulgaris: a systematic review of pre-clinical and early-phase clinical evidence. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13092156.","journal-title":"Biomedicines"},{"key":"3345_CR65","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1166\/jnn.2015.9184","volume":"15","author":"EL Silva","year":"2015","unstructured":"Silva EL, Carneiro G, De Ara\u00fajo LA, Vaz Trindade MDJ, Yoshida MI, Or\u00e9fice RL, et al. Solid lipid nanoparticles loaded with retinoic acid and lauric acid as an alternative for topical treatment of acne vulgaris. J Nanosci Nanotechnol American Scientific Publishers. 2015;15:792\u20139. https:\/\/doi.org\/10.1166\/jnn.2015.9184.","journal-title":"J Nanosci Nanotechnol American Scientific Publishers"},{"key":"3345_CR66","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.colsurfb.2014.05.041","volume":"121","author":"AK Jain","year":"2014","unstructured":"Jain AK, Jain A, Garg NK, Agarwal A, Jain A, Jain SA, et al. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf B Biointerfaces. 2014;121:222\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.05.041.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3345_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104149","author":"R Pawar","year":"2023","unstructured":"Pawar R, Dawre S. Solid lipid nanoparticles dispersed topical hydrogel for co-delivery of adapalene and minocycline for acne treatment. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104149.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3345_CR68","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2147\/IJN.S497108","volume":"20","author":"F Abid","year":"2025","unstructured":"Abid F, Kim S, Savaliya B, Cesari L, Amirmostofian M, Abdella S, et al. Targeting acne: development of monensin-loaded nanostructured lipid carriers. Int J Nanomedicine. 2025;20:2181\u2013204. https:\/\/doi.org\/10.2147\/IJN.S497108.","journal-title":"Int J Nanomedicine"},{"key":"3345_CR69","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3109\/03639045.2015.1104343","volume":"42","author":"A Jain","year":"2016","unstructured":"Jain A, Garg NK, Jain A, Kesharwani P, Jain AK, Nirbhavane P, et al. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne. Drug Dev Ind Pharm. 2016;42:897\u2013905. https:\/\/doi.org\/10.3109\/03639045.2015.1104343.","journal-title":"Drug Dev Ind Pharm"},{"key":"3345_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jddst.2018.07.008","volume":"47","author":"DS Malik","year":"2018","unstructured":"Malik DS, Kaur G, Editions de Sante. Nanostructured gel for topical delivery of azelaic acid: designing, characterization, and in-vitro evaluation. J Drug Deliv Sci Technol. 2018;47:123\u201336. https:\/\/doi.org\/10.1016\/j.jddst.2018.07.008.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3345_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101418","volume":"55","author":"D Singh","year":"2020","unstructured":"Singh D, Kaur G, Elsevier. Exploring therapeutic potential of azelaic acid loaded nlcs for the treatment of acne vulgaris. J Drug Deliv Sci Technol. 2020;55:101418. https:\/\/doi.org\/10.1016\/j.jddst.2019.101418.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3345_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.colsurfb.2016.05.042","volume":"146","author":"HR Kelidari","year":"2016","unstructured":"Kelidari HR, Saeedi M, Hajheydari Z, Akbari J, Morteza-Semnani K, Akhtari J, et al. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial. Colloids Surf B Biointerfaces. 2016;146:47\u201353. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.05.042.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3345_CR73","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000488993","volume":"31","author":"M Sabouri","year":"2018","unstructured":"Sabouri M, Samadi A, Ahmad Nasrollahi S, Farboud ES, Mirrahimi B, Hassanzadeh H, et al. Tretinoin loaded nanoemulsion for acne vulgaris: Fabrication, physicochemical and clinical efficacy assessments. Skin Pharmacol Physiol S Karger AG. 2018;31:316\u201323. https:\/\/doi.org\/10.1159\/000488993.","journal-title":"Skin Pharmacol Physiol S Karger AG"},{"key":"3345_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2024.102063","volume":"32","author":"R Alfaraj","year":"2024","unstructured":"Alfaraj R, Hababah S, Eltayb EK, Alqahtani FY, Aleanizy FS. Isotretinoin self-nano-emulsifying drug delivery system: preparation, optimization and antibacterial evaluation. Saudi Pharm J. 2024;32:102063. https:\/\/doi.org\/10.1016\/j.jsps.2024.102063.","journal-title":"Saudi Pharm J"},{"key":"3345_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.113771","volume":"315","author":"VK Rapalli","year":"2020","unstructured":"Rapalli VK, Waghule T, Hans N, Mahmood A, Gorantla S, Dubey SK, et al. Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders. J Mol Liq [Internet]. 2020;315:113771. https:\/\/doi.org\/10.1016\/j.molliq.2020.113771.","journal-title":"J Mol Liq [Internet]"},{"key":"3345_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124879","volume":"667","author":"CM Gowda","year":"2024","unstructured":"Gowda CM, Wairkar S. Azelaic acid-based lyotropic liquid crystals gel for acne vulgaris: formulation optimization, antimicrobial activity and dermatopharmacokinetic study. Int J Pharm [Internet]. 2024;667:124879. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124879.","journal-title":"Int J Pharm [Internet]"},{"key":"3345_CR77","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03106-7","author":"A Sedighidarijani","year":"2025","unstructured":"Sedighidarijani A, Golmohammadzadeh S, Kamali H, Khameneh B, Khodaverdi E, Nokhodchi A. Isotretinoin-loaded topical lipid liquid crystal for the treatment of acne: in-vitro and in-vivo evaluations. AAPS PharmSciTech. 2025. https:\/\/doi.org\/10.1208\/s12249-025-03106-7.","journal-title":"AAPS PharmSciTech"},{"key":"3345_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040554","author":"N Magrode","year":"2024","unstructured":"Magrode N, Poomanee W, Kiattisin K, Ampasavate C. Microemulsions and nanoemulsions for topical delivery of tripeptide-3: from design of experiment to anti-sebum efficacy on facial skin. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16040554.","journal-title":"Pharmaceutics"},{"key":"3345_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030633","author":"E Subroto","year":"2023","unstructured":"Subroto E, Andoyo R, Indiarto R. Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds. Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12030633.","journal-title":"Antioxidants"},{"key":"3345_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2023.100205","volume":"6","author":"T Chantaburanan","year":"2023","unstructured":"Chantaburanan T, Teeranachaideekul V, Jintapattanakit A, Chantasart D, Junyaprasert VB. Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: effect of surfactant and lipid compositions. International Journal of Pharmaceutics: X. 2023;6:100205. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100205.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3345_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/frsfm.2025.1658466","author":"P Subash","year":"2025","unstructured":"Subash P, Khute S. Recent advances in lyotropic liquid crystal nanoparticle formulations for drug delivery systems. Frontiers in Soft Matter. 2025. https:\/\/doi.org\/10.3389\/frsfm.2025.1658466.","journal-title":"Frontiers in Soft Matter"},{"key":"3345_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/gels9020135","author":"A Arooj","year":"2023","unstructured":"Arooj A, Rehman AU, Iqbal M, Naz I, Alhodaib A, Ahmed N. Development of adapalene loaded liposome based gel for acne. Gels. 2023. https:\/\/doi.org\/10.3390\/gels9020135.","journal-title":"Gels"},{"key":"3345_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114233","volume":"197","author":"A Abruzzo","year":"2024","unstructured":"Abruzzo A, Pucci R, Abruzzo PM, Canaider S, Parolin C, Vitali B, et al. Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties. Eur J Pharm Biopharm. 2024;197:114233. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114233.","journal-title":"Eur J Pharm Biopharm"},{"key":"3345_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47302-6","author":"P Ghasemiyeh","year":"2023","unstructured":"Ghasemiyeh P, Moradishooli F, Daneshamouz S, Heidari R, Niroumand U, Mohammadi-Samani S, et al. Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-47302-6.","journal-title":"Sci Rep"},{"key":"3345_CR85","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/IJN.S70449","volume":"10","author":"A Gupta","year":"2014","unstructured":"Gupta A, Singh S, Kotla NG, Webster TJ, Dove Medical Press Ltd. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine. 2014;10:171\u201382. https:\/\/doi.org\/10.2147\/IJN.S70449.","journal-title":"Int J Nanomedicine"},{"key":"3345_CR86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejpb.2017.01.006","volume":"114","author":"C Csongradi","year":"2017","unstructured":"Csongradi C, du Plessis J, Aucamp ME, Gerber M, Elsevier B.V. Topical delivery of roxithromycin solid-state forms entrapped in vesicles. Eur J Pharm Biopharm. 2017;114:96\u2013107. https:\/\/doi.org\/10.1016\/j.ejpb.2017.01.006.","journal-title":"Eur J Pharm Biopharm"},{"key":"3345_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122940","volume":"639","author":"H Abd-allah","year":"2023","unstructured":"Abd-allah H, Ragaie MH, Elmowafy E. Unraveling the pharmaceutical and clinical relevance of the influence of syringic acid loaded linoleic acid transferosomes on acne. Int J Pharm. 2023;639:122940. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122940.","journal-title":"Int J Pharm"},{"key":"3345_CR88","doi-asserted-by":"publisher","unstructured":"Nayeem U, Garg A, Das AK, Shree N, Yasmeen, Sultana Y, et al. Development and evaluation of the novel chitosan-based 1% clindamycin & 2.5% benzoyl peroxide transferosomal gel for topical acne treatment. J Drug Deliv Sci Technol [Internet]. 2023;89:105002. https:\/\/doi.org\/10.1016\/j.jddst.2023.105002","DOI":"10.1016\/j.jddst.2023.105002"},{"key":"3345_CR89","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1208\/s12249-018-1025-0","volume":"19","author":"MA El-Nabarawi","year":"2018","unstructured":"El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM, Springer New York LLC. Dapsone-loaded invasomes as a potential treatment of acne: preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech. 2018;19:2174\u201384. https:\/\/doi.org\/10.1208\/s12249-018-1025-0.","journal-title":"AAPS PharmSciTech"},{"key":"3345_CR90","doi-asserted-by":"crossref","unstructured":"Ahmed El-Nabarawi M, Shamma RN, Farouk F, Nasralla SM, Shamma RN. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: Preparation, characterization and in-vivo skin deposition assay.\u00a0J Liposome Res. 2020;30(1):1-11","DOI":"10.1080\/08982104.2019.1577256"},{"key":"3345_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-025-01989-1","volume":"15","author":"UY Kandekar","year":"2025","unstructured":"Kandekar UY, Khairnar AP, Pandit AP. Novel Aspasomal gel formulation with enhanced dapsone solubility for effective treatment of acne. Bionanoscience. 2025;15:393. https:\/\/doi.org\/10.1007\/s12668-025-01989-1.","journal-title":"Bionanoscience"},{"key":"3345_CR92","doi-asserted-by":"publisher","unstructured":"Giannopoulos-Dimitriou A, Saiti A, Petrou A, Vizirianakis IS, Fatouros DG. Liposome stability and integrity. In: Antimisiaris SG, editor. Liposomes in Drug Delivery: What, where, how and when to Deliver [Internet]. Academic Press; 2024. p. 89\u2013121. https:\/\/doi.org\/10.1016\/B978-0-443-15491-1.00022-5","DOI":"10.1016\/B978-0-443-15491-1.00022-5"},{"key":"3345_CR93","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ajps.2018.02.004","volume":"13","author":"T Amnuaikit","year":"2018","unstructured":"Amnuaikit T, Limsuwan T, Khongkow P, Boonme P. Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes. Asian J Pharm Sci. 2018;13:472\u201384. https:\/\/doi.org\/10.1016\/j.ajps.2018.02.004.","journal-title":"Asian J Pharm Sci"},{"key":"3345_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03660-z","volume":"23","author":"A Choudhury","year":"2025","unstructured":"Choudhury A, Kirti A, Lenka SS, Naser SS, Sinha A, Kumari S, et al. Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis. J Nanobiotechnology. 2025;23:576. https:\/\/doi.org\/10.1186\/s12951-025-03660-z.","journal-title":"J Nanobiotechnology"},{"key":"3345_CR95","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.xphs.2017.05.038","volume":"106","author":"MA Sallam","year":"2017","unstructured":"Sallam MA, Mar\u00edn Bosc\u00e1 MT, Elsevier B.V. Mechanistic analysis of human skin distribution and follicular targeting of adapalene-loaded biodegradable nanospheres with an insight into hydrogel matrix influence, in\u00a0vitro skin irritation, and in\u00a0vivo tolerability. J Pharm Sci. 2017;106:3140\u20139. https:\/\/doi.org\/10.1016\/j.xphs.2017.05.038.","journal-title":"J Pharm Sci"},{"key":"3345_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112101","volume":"208","author":"R Ferreira-Nunes","year":"2021","unstructured":"Ferreira-Nunes R, Cunha-Filho M, Gratieri T, Gelfuso GM. Follicular-targeted delivery of spironolactone provided by polymeric nanoparticles. Colloids Surf B Biointerfaces. 2021;208:112101. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112101.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3345_CR97","doi-asserted-by":"publisher","first-page":"13728","DOI":"10.1039\/D3NR01789C","volume":"15","author":"F Abid","year":"2023","unstructured":"Abid F, Savaliya B, Parikh A, Kim S, Amirmostofian M, Cesari L, et al. Nanotechnology and narasin: a powerful combination against acne. Nanoscale. 2023;15:13728\u201339. https:\/\/doi.org\/10.1039\/D3NR01789C.","journal-title":"Nanoscale"},{"key":"3345_CR98","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.colsurfb.2016.07.029","volume":"146","author":"E Kahraman","year":"2016","unstructured":"Kahraman E, \u00d6zhan G, \u00d6zsoy Y, G\u00fcng\u00f6r S. Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment. Colloids Surf B Biointerfaces. 2016;146:692\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.07.029.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3345_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51392-1","volume":"14","author":"RM Yehia","year":"2024","unstructured":"Yehia RM, Teaima MH, Ragaie MH, Elmazar MM, Attia DA, El-Nabarawi MA. Resolving acne with optimized adapalene microspongeal gel, in vivo and clinical evaluations. Sci Rep. 2024;14:1359. https:\/\/doi.org\/10.1038\/s41598-024-51392-1.","journal-title":"Sci Rep"},{"key":"3345_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2023.100013","volume":"2","author":"H Bhardwaj","year":"2023","unstructured":"Bhardwaj H, Jangde RK. Current updated review on preparation of polymeric nanoparticles for drug delivery and biomedical applications. Next Nanotechnology. 2023;2:100013. https:\/\/doi.org\/10.1016\/j.nxnano.2023.100013.","journal-title":"Next Nanotechnology"},{"key":"3345_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018026009","volume":"37","author":"R Gupta","year":"2018","unstructured":"Gupta R, Xie H. Nanoparticles in daily life: applications, toxicity and regulations. J Environ Pathol Toxicol Oncol. 2018;37:209\u201330. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2018026009.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"3345_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-024-04118-1","volume":"19","author":"U Havelikar","year":"2024","unstructured":"Havelikar U, Ghorpade KB, Kumar A, Patel A, Singh M, Banjare N, et al. Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines. Discover Nano. 2024;19:165. https:\/\/doi.org\/10.1186\/s11671-024-04118-1.","journal-title":"Discover Nano"},{"key":"3345_CR103","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","volume":"19","author":"R Tenchov","year":"2025","unstructured":"Tenchov R, Hughes KJ, Ganesan M, Iyer KA, Ralhan K, Lotti Diaz LM, et al. Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery. ACS Nano. 2025;19:4011\u201338. https:\/\/doi.org\/10.1021\/acsnano.4c09566.","journal-title":"ACS Nano"},{"key":"3345_CR104","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/17425247.2021.1951218","volume":"18","author":"AC Paiva-Santos","year":"2021","unstructured":"Paiva-Santos AC, Mascarenhas-Melo F, Coimbra SC, Pawar KD, Peixoto D, Ch\u00e1-Ch\u00e1 R, et al. Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients. Expert Opin Drug Deliv. 2021;18:1435\u201354. https:\/\/doi.org\/10.1080\/17425247.2021.1951218.","journal-title":"Expert Opin Drug Deliv"},{"key":"3345_CR105","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2024.2372269","author":"Y Lei","year":"2024","unstructured":"Lei Y, Jiang W, Peng C, Wu D, Wu J, Xu Y, et al. Advances in polymeric nano-delivery systems targeting hair follicles for the treatment of acne. Drug Deliv. 2024. https:\/\/doi.org\/10.1080\/10717544.2024.2372269.","journal-title":"Drug Deliv"},{"key":"3345_CR106","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.2147\/IJN.S301597","volume":"16","author":"HF Salem","year":"2021","unstructured":"Salem HF, Kharshoum RM, Awad SM, Mostafa MA, Abou-Taleb HA. Tailoring of retinyl palmitate-based ethosomal hydrogel as a novel nanoplatform for acne vulgaris management: fabrication, optimization, and clinical evaluation employing a split-face comparative study. Int J Nanomedicine. 2021;16:4251\u201376. https:\/\/doi.org\/10.2147\/IJN.S301597.","journal-title":"Int J Nanomedicine"},{"key":"3345_CR107","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000488993","volume":"31","author":"M Sabouri","year":"2018","unstructured":"Sabouri M, Samadi A, Ahmad Nasrollahi S, Farboud ES, Mirrahimi B, Hassanzadeh H, et al. Tretinoin loaded nanoemulsion for acne vulgaris: Fabrication, physicochemical and clinical efficacy assessments. Skin Pharmacol Physiol. 2018;31:316\u201323. https:\/\/doi.org\/10.1159\/000488993.","journal-title":"Skin Pharmacol Physiol"},{"key":"3345_CR108","doi-asserted-by":"publisher","unstructured":"Samadi A, Sartipi Z, Ahmad Nasrollahi S, Sheikholeslami B, Nassiri Kashani M, Rouini MR, et al. Efficacy assessments of tretinoin-loaded nano lipid carriers in acne vulgaris: a double blind, split-face randomized clinical study. Arch Dermatol Res. Springer Berlin Heidelberg; 2022;314:553\u201361. https:\/\/doi.org\/10.1007\/s00403-021-02256-5","DOI":"10.1007\/s00403-021-02256-5"},{"key":"3345_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-51392-1","volume":"14","author":"RM Yehia","year":"2024","unstructured":"Yehia RM, Teaima MH, Ragaie MH, Elmazar MM, Attia DA, El-Nabarawi MA. Resolving acne with optimized adapalene microspongeal gel, in vivo and clinical evaluations. Sci Rep Nature Publishing Group UK. 2024;14:1\u201323. https:\/\/doi.org\/10.1038\/s41598-024-51392-1.","journal-title":"Sci Rep Nature Publishing Group UK"},{"key":"3345_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.colsurfb.2016.05.042","volume":"146","author":"HR Kelidari","year":"2016","unstructured":"Kelidari HR, Saeedi M, Hajheydari Z, Akbari J, Morteza-Semnani K, Akhtari J, et al. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: a randomized, double-blind, prospective trial. Colloids Surf B Biointerfaces. 2016;146:47\u201353. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.05.042.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3345_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ph16010128","author":"R Albash","year":"2023","unstructured":"Albash R, Badawi NM, Hamed MIA, Ragaie MH, Mohammed SS, Elbesh RM, et al. Exploring the synergistic effect of bergamot essential oil with spironolactone loaded nano-phytosomes for treatment of acne vulgaris: in vitro optimization, in silico studies, and clinical evaluation. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16010128.","journal-title":"Pharmaceuticals"},{"key":"3345_CR112","doi-asserted-by":"publisher","unstructured":"Mohsin N, Hernandez LE, Martin MR, Does A Vander, Nouri K. Acne treatment review and future perspectives. Dermatol Ther. John Wiley and Sons Inc; 2022. https:\/\/doi.org\/10.1111\/dth.15719","DOI":"10.1111\/dth.15719"},{"key":"3345_CR113","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-4632.2010.04416.x","volume":"49","author":"B Dr\u00e9no","year":"2010","unstructured":"Dr\u00e9no B, Thiboutot D, Gollnick H, Finlay AY, Layton A, Leyden JJ, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49:448\u201356. https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04416.x.","journal-title":"Int J Dermatol"},{"key":"3345_CR114","doi-asserted-by":"publisher","unstructured":"Salamzadeh J, Torabi Kachousangi S, Hamzelou S, Naderi S, Daneshvar E. Medication adherence and its possible associated factors in patients with acne vulgaris: A cross-sectional study of 200 patients in Iran. Dermatol Ther. Blackwell Publishing Inc.; 2020;33. https:\/\/doi.org\/10.1111\/dth.14408","DOI":"10.1111\/dth.14408"},{"key":"3345_CR115","doi-asserted-by":"publisher","unstructured":"Abdulrahman N, Alsubeeh, Alsharafi AA, Ahamed SS, Alajlan A. Treatment adherence among patients with five dermatological diseases and four treatment types-a cross-sectional study. Patient Prefer Adherence. Dove Medical Press Ltd.; 2019;13:2029\u201338. https:\/\/doi.org\/10.2147\/PPA.S230921","DOI":"10.2147\/PPA.S230921"},{"key":"3345_CR116","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.2147\/PPA.S555557","volume":"19","author":"A Paichitrojjana","year":"2025","unstructured":"Paichitrojjana A, Paichitrojjana A. Real-world acne treatment patterns, preferences, and adherence in Thailand: a cross-sectional analysis. Patient Prefer Adherence. 2025;19:3197\u2013210. https:\/\/doi.org\/10.2147\/PPA.S555557.","journal-title":"Patient Prefer Adherence"},{"key":"3345_CR117","doi-asserted-by":"publisher","unstructured":"C\u00eerstea N, Radu A, Vesa C, Radu AF, Bungau AF, Tit DM, et al. Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates. Cureus. Springer Science and Business Media LLC; 2024; https:\/\/doi.org\/10.7759\/cureus.69764","DOI":"10.7759\/cureus.69764"},{"key":"3345_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/cells14211650","volume":"14","author":"JW \u0141uczak","year":"2025","unstructured":"\u0141uczak JW, Palusi\u0144ska M, Ma\u015bli\u0144ska-Gromadka K, Pietrzak D, Szopi\u0144ski T, Lewicki S, et al. The next generation of skin care: transforming retinoid therapeutics. Cells. 2025;14:1650. https:\/\/doi.org\/10.3390\/cells14211650.","journal-title":"Cells"},{"key":"3345_CR119","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2217\/nnm-2021-0031","volume":"16","author":"FA Lima","year":"2021","unstructured":"Lima FA, Vilela RVR, Or\u00e9fice RL, Silva IR, Reis ECO, Carvalho LAC, et al. Nanostructured lipid carriers enhances the safety profile of tretinoin: And healthy human volunteers\u2019 studies. Nanomedicine Future Medicine Ltd. 2021;16:1391\u2013409. https:\/\/doi.org\/10.2217\/nnm-2021-0031.","journal-title":"Nanomedicine Future Medicine Ltd"},{"key":"3345_CR120","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16415","author":"J Zhong","year":"2024","unstructured":"Zhong J, Zhao N, Song Q, Du Z, Shu P. Topical retinoids: novel derivatives, nano lipid-based carriers, and combinations to improve chemical instability and skin irritation. J Cosmet Dermatol. 2024. https:\/\/doi.org\/10.1111\/jocd.16415.","journal-title":"J Cosmet Dermatol"},{"key":"3345_CR121","doi-asserted-by":"publisher","first-page":"156","DOI":"10.30574\/gscbps.2025.31.1.0150","volume":"31","author":"LalitD. Mahure","year":"2025","unstructured":"Mahure Lalit D., Hatwar Pooja R, Bakal Ravindra L, Turankar Chetan C. Nanotechnology-based approaches for acne treatment: a comprehensive review. GSC Biological and Pharmaceutical Sciences. 2025;31:156\u201362. https:\/\/doi.org\/10.30574\/gscbps.2025.31.1.0150.","journal-title":"GSC Biological and Pharmaceutical Sciences"},{"key":"3345_CR122","first-page":"1","volume":"8","author":"YB Lee","year":"2019","unstructured":"Lee YB, Byun EJ, Kim HS. Potential role of the microbiome in acne: a comprehensive review. J Clin Med. 2019;8:1\u201325.","journal-title":"J Clin Med"},{"key":"3345_CR123","doi-asserted-by":"publisher","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I, Carreira B, Pozzi S, Ac\u00farcio RC, et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. Springer US; 2022;12:500\u201325. https:\/\/doi.org\/10.1007\/s13346-021-01024-2","DOI":"10.1007\/s13346-021-01024-2"},{"key":"3345_CR124","doi-asserted-by":"publisher","DOI":"10.1039\/d3an01739g","author":"Y Shen","year":"2023","unstructured":"Shen Y, Gwak H, Han B. Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics. Analyst. 2023. https:\/\/doi.org\/10.1039\/d3an01739g.","journal-title":"Analyst"},{"key":"3345_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics8020039","author":"D Khater","year":"2021","unstructured":"Khater D, Nsairat H, Odeh F, Saleh M, Jaber A, Alshaer W, et al. Design, preparation, and characterization of effective dermal and transdermal lipid nanoparticles: a review. Cosmetics. 2021. https:\/\/doi.org\/10.3390\/cosmetics8020039.","journal-title":"Cosmetics"},{"key":"3345_CR126","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2217\/nnm-2019-0130","volume":"14","author":"R Bosetti","year":"2019","unstructured":"Bosetti R, Jones SL. Cost-effectiveness of nanomedicine: estimating the real size of nano-costs. Nanomedicine. 2019;14:1367\u201370. https:\/\/doi.org\/10.2217\/nnm-2019-0130.","journal-title":"Nanomedicine"},{"key":"3345_CR127","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","volume":"28","author":"I Cs\u00f3ka","year":"2021","unstructured":"Cs\u00f3ka I, Ismail R, J\u00f3j\u00e1rt-Laczkovich O, Pallagi E. Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine Development. Curr Med Chem. 2021;28:7461\u201376. https:\/\/doi.org\/10.2174\/0929867328666210406115529.","journal-title":"Curr Med Chem"},{"key":"3345_CR128","first-page":"1","volume":"2","author":"E Commission","year":"2007","unstructured":"Commission E. Medicinal Products for Human Use. 2007;2:1\u201334.","journal-title":"Medicinal Products for Human Use"},{"key":"3345_CR129","doi-asserted-by":"publisher","unstructured":"T\u00f6ren E. Nanomaterial Penetration in Compromised Skin\u202f: A Critical Review of Toxicological Risks and Knowledge Gaps. 2025;\u00a0https:\/\/doi.org\/10.5281\/zenodo.14788186","DOI":"10.5281\/zenodo.14788186"},{"key":"3345_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-024-04118-1","author":"U Havelikar","year":"2024","unstructured":"Havelikar U, Ghorpade KB, Kumar A, Patel A, Singh M, Banjare N, et al. Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines. Discover Nano. 2024. https:\/\/doi.org\/10.1186\/s11671-024-04118-1.","journal-title":"Discover Nano"},{"key":"3345_CR131","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210406115529","author":"I Csoka","year":"2021","unstructured":"Csoka I, Ismail R, J\u00f3j\u00e1rt-Laczkovich O, Pallagi E. Regulatory considerations, challenges and risk-based approach in nanomedicine development. Curr Med Chem. 2021. https:\/\/doi.org\/10.2174\/0929867328666210406115529.","journal-title":"Curr Med Chem"},{"key":"3345_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030309","author":"N Dragicevic","year":"2024","unstructured":"Dragicevic N, Maibach HI. Liposomes and other nanocarriers for the treatment of acne vulgaris: improved therapeutic efficacy and skin tolerability. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16030309.","journal-title":"Pharmaceutics"},{"key":"3345_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202107960","volume":"61","author":"N Tiwari","year":"2022","unstructured":"Tiwari N, Osorio-Blanco ER, Sonzogni A, Esporr\u00edn-Ubieto D, Wang H, Calder\u00f3n M. Nanocarriers for skin applications: where do we stand? Angew Chem Int Ed. 2022;61:e202107960. https:\/\/doi.org\/10.1002\/anie.202107960.","journal-title":"Angew Chem Int Ed"},{"key":"3345_CR134","doi-asserted-by":"publisher","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","volume":"8","author":"N Raina","year":"2023","unstructured":"Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS Omega. 2023;8:19145\u201367. https:\/\/doi.org\/10.1021\/acsomega.2c08016.","journal-title":"ACS Omega"},{"key":"3345_CR135","unstructured":"Food and Drug Administration (FDA). Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry [Internet]. New Hampshire Ave; 2022 Apr. https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htmand\/or.\u00a0Accessed 19 Apr 2025 ."},{"key":"3345_CR136","unstructured":"Food and Drug Administration (FDA). Guidance for Industry- Safety of Nanomaterials in Cosmetic Products [Internet]. New Hampshire Ave; 2014 Jun. http:\/\/www.regulations.gov.\u00a0Accessed 19 Apr 2025."},{"key":"3345_CR137","first-page":"1","volume":"95","author":"S Committee","year":"2007","unstructured":"Committee S, Sccp CP. Scientific Committee on Consumer Products PRELIMINARY OPINION ON. In Vivo (Brooklyn). 2007;95:1\u201356.","journal-title":"In Vivo (Brooklyn)"},{"key":"3345_CR138","unstructured":"Cilurzo F, Catalano A, Paolino D, Fresta M, Marra A, Oppedinaso G. Nanocarrier for Transfollicular Delivery of Active Substances and Associated Formation Process. Art. WO Patent Application WO2017046728A1. Italy: World Intellectual Property Organization International Bureau; 2017. p. 1\u201326."},{"key":"3345_CR139","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L, Cartwright M, Gerloni M, Fragasso E, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156:621\u201330. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0465.","journal-title":"JAMA Dermatol"},{"key":"3345_CR140","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1021\/acsomega.0c01818","volume":"5","author":"B Salehi","year":"2020","unstructured":"Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, et al. Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega. 2020;5:11849\u201372. https:\/\/doi.org\/10.1021\/acsomega.0c01818.","journal-title":"ACS Omega"},{"key":"3345_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107557","volume":"96","author":"HJ Lim","year":"2021","unstructured":"Lim HJ, Kang SH, Song YJ, Jeon YD, Jin JS. Inhibitory effect of quercetin on Propionibacterium acnes-induced skin inflammation. Int Immunopharmacol. 2021;96:107557. https:\/\/doi.org\/10.1016\/j.intimp.2021.107557.","journal-title":"Int Immunopharmacol"},{"key":"3345_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules29133206","volume":"29","author":"MK Zaborowski","year":"2024","unstructured":"Zaborowski MK, D\u0142ugosz A, B\u0142aszak B, Szulc J, Leis K. The role of quercetin as a plant-derived bioactive agent in preventive medicine and treatment in skin disorders. Molecules. 2024;29:1\u201316. https:\/\/doi.org\/10.3390\/molecules29133206.","journal-title":"Molecules"},{"key":"3345_CR143","unstructured":"Leonard C. DeBenedictis, Joel N. Jimenez Lozano, Like Zeng, George Frangineas Jr, Linda Pham. Skin Freezing System for Treating Acne and Skin Condition. US Patent Application US20240164938A1. United States Patent and Trademark Office; 2024. p. 1\u201366."},{"key":"3345_CR144","unstructured":"Todd James Harris, Alice Ann Chen Kim. Compositions and methods for thermal skin treatment with metal nanoparticles. US Patent Application US20240099758A1. United States Patent and Trademark Office; 2024. p. 1\u201336."},{"key":"3345_CR145","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1021\/acsphotonics.4c00491","volume":"11","author":"GN Naidu","year":"2024","unstructured":"Naidu GN, Kadria-Vili Y, Neumann O, Halas NJ, Nordlander P, Alabastri A. Routes to optimizing photothermal cancer therapy through a comprehensive theoretical model. ACS Photonics. 2024;11:2681.","journal-title":"ACS Photonics"},{"key":"3345_CR146","doi-asserted-by":"publisher","DOI":"10.1111\/srt.70045","volume":"30","author":"JY Hong","year":"2024","unstructured":"Hong JY, Kim KR, Kim HJ, Seok J, Park KY, John Wiley & Sons, Ltd. Targeted precision cryotherapy for acne vulgaris. Skin Res Technol. 2024;30:e70045. https:\/\/doi.org\/10.1111\/srt.70045.","journal-title":"Skin Res Technol"},{"key":"3345_CR147","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00144","author":"P Khairnar","year":"2024","unstructured":"Khairnar P, Phatale V, Shukla S, Tijani AO, Hedaoo A, Strauss J, et al. Nanocarrier-integrated microneedles: divulging the potential of novel frontiers for fostering the management of skin ailments. Mol Pharm. 2024. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00144.","journal-title":"Mol Pharm"},{"key":"3345_CR148","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-025-01662-y","author":"Y Han","year":"2025","unstructured":"Han Y, Qin X, Lin W, Wang C, Yin X, Wu J, et al. Microneedle-based approaches for skin disease treatment. Nanomicro Lett. 2025. https:\/\/doi.org\/10.1007\/s40820-025-01662-y.","journal-title":"Nanomicro Lett"},{"key":"3345_CR149","doi-asserted-by":"publisher","first-page":"48433","DOI":"10.1021\/acsami.1c15673","volume":"13","author":"T Wen","year":"2021","unstructured":"Wen T, Lin Z, Zhao Y, Zhou Y, Niu B, Shi C, et al. Bioresponsive nanoarchitectonics-integrated microneedles for amplified chemo-photodynamic therapy against acne vulgaris. ACS Appl Mater Interfaces. 2021;13:48433\u201348. https:\/\/doi.org\/10.1021\/acsami.1c15673.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3345_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124961","author":"Wyu Cao","year":"2024","unstructured":"Cao Wyu, Zhao Hqing, Gu X, Shao Wjun, Zheng Ljie, Zeng Qya, et al. Light-responsive antibacterial dissolving microneedles loaded with 5-aminolevulinic acid and silver nanoparticles for the treatment of acne. Int J Pharm. 2024. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124961.","journal-title":"Int J Pharm"},{"key":"3345_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.163339","author":"H Li","year":"2025","unstructured":"Li H, Li H, Kou Y, Chen W, He K, Wen D, et al. Multifunctional nanocomposite-driven microneedles enabling bacteria capturing, detecting, and killing for precision treatment of acne with varying severities. Chem Eng J. 2025. https:\/\/doi.org\/10.1016\/j.cej.2025.163339.","journal-title":"Chem Eng J"},{"key":"3345_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130296","volume":"263","author":"PC Pires","year":"2024","unstructured":"Pires PC, Damiri F, Zare EN, Hasan A, Neisiany RE, Veiga F, et al. A review on natural biopolymers in external drug delivery systems for wound healing and atopic dermatitis. Int J Biol Macromol. 2024;263:130296. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130296.","journal-title":"Int J Biol Macromol"},{"key":"3345_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.nwnano.2025.100108","volume":"10","author":"GoudanavarP. Balaji","year":"2025","unstructured":"Balaji Goudanavar P. Advancing topical drug delivery: NLC innovations in dermatological therepeutics. Nano Trends. 2025;10:100108. https:\/\/doi.org\/10.1016\/j.nwnano.2025.100108.","journal-title":"Nano Trends"},{"key":"3345_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2025.e00913","volume":"47","author":"A Ayub","year":"2025","unstructured":"Ayub A, Wani AK, Malik SM, Ayub M, Singh R, Chopra C, et al. Green nanoscience for healthcare: advancing biomedical innovation through eco-synthesized nanoparticle. Biotechnol Rep. 2025;47:e00913. https:\/\/doi.org\/10.1016\/j.btre.2025.e00913.","journal-title":"Biotechnol Rep"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03345-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:51:33Z","timestamp":1780390293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03345-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":154,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3345"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03345-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"143"}}